ObsEva Announces Progress on Restructuring Initiatives
$7.6 million annual savings expected via reduction-in-force currently underway $6.2 million savings expected from assignment…
$7.6 million annual savings expected via reduction-in-force currently underway $6.2 million savings expected from assignment…
TOKYO, Sep 13, 2022 – (JCN Newswire) – Honda Motor Co., Ltd. will showcase its…
SEOUL, S.KOREA, Sep 13, 2022 – (ACN Newswire) – ONBUFF has announced the launch of…
Findings from Falcon Overwatch threat hunters showed faster breakout times by eCrime adversaries and one…
Mr. Kim Brings Significant Global Private Equity and Leveraged Finance Experience to Support Ares’ Continued…
The LARYCARE study aims at discovering new predictive biomarkers to treatment response and at developing…
Seven regional winners are all leveraging intent data to drive breakthrough digital results NEWTON, Mass.–(BUSINESS…
HAYWARD, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) — Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or…
HERE SDK Navigate now available in Japan HERE SDK Navigate now available in Japan …
Internet City, Dubai–(Newsfile Corp. – September 12, 2022) – LBank Exchange, a global digital asset…
HOUSTON–(BUSINESS WIRE)–Crestwood Equity Partners LP (NYSE: CEQP) (“Crestwood”) today announced the pricing of the previously…
Announced completion of first dose level and enrollment initiation for second dose level in investigator-sponsored…
LAWRENCEVILLE, N.J., Sept. 12, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), a clinical-stage drug development…
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals, Inc. (HKEX:1228) , a China and U.S.-based global biopharmaceutical…
JERUSALEM, Sept. 12, 2022 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the…
Investor Teleconference and Webcast Scheduled Tomorrow, September 13, 2022, at 7:30 a.m. EDT CAMBRIDGE, Mass.,…
Legendary Baseball Pitcher and Avid Golfer Uses VAZALORE® 325 mg for Fast, Effective Pain Relief…
Pioneer Entertainment Executive to Extend Digital Media Expertise to Company’s Mission in Tobacco Harm Reduction…
WALTHAM, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical…
The clinical trial of Tempol has reached the initial planned enrollment of 248 subjects Independent…